#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alagille syndrome Chronic graft versus host disease Hairy cell leukaemia Inborn error of metabolism Cortical dysplasia Diffuse large B-cell lymphoma refractory Methylmalonic acidaemia Ocular myasthenia Thrombocytosis Immunodeficiency Arrhythmia Autoimmune myositis Dementia Juvenile chronic myelomonocytic leukaemia Thrombotic microangiopathy More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Treatment Leiomyosarcoma recurrent – Diagnostics Hyperoxaluria – Life with Disease Hepatoblastoma Cystic fibrosis lung Systemic sclerosis pulmonary Marginal zone lymphoma – Trials in Disease Chronic granulomatous disease – Treatment Chondrosarcoma metastatic – Life with Disease Skin angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nilotinib Piromelatine Berubicin Hydrochloride Dfv890 Tryptophan Burfiralimab Triptorelin Colestyramine Pervi-Neo Riliprubart 64CU-PSMA I&T Linperlisib Quavonlimab Dexketoprofen Diltiazem Sevoflurane Camonsertib Alanyl Glutamine Balcinrenone Ruzasvir More therapies…

    Learn about Your Condition

    Procedural hypotension Rhabdoid tumour Non-obstructive cardiomyopathy Hyperlipidaemia Small intestine leiomyosarcoma Pyoderma Hypoparathyroidism Oropharyngeal cancer Mantle cell lymphoma stage IV Diabetic ketoacidosis Merycism Inner ear disorder Lumbosacral radiculopathy Magnetic resonance imaging Pterygium More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Juvenile idiopathic arthritis

  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    • Polymyalgia rheumatica
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    • Still’s disease
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Study on the Safety and Effectiveness of Adalimumab and Etanercept in Children with Active Juvenile Idiopathic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Etanercept
    • Adalimumab
    Italy

  • Study on the Effectiveness of Triamcinolone Hexacetonide Injections for Juvenile Idiopathic Arthritis in Patients Starting TNF Inhibitor Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Triamcinolone Hexacetonide
    Norway

  • Long-Term Study of Tofacitinib for Children and Teens with Juvenile Idiopathic Arthritis

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Tofacitinib
    • Tofacitinib Citrate
    Belgium Poland Spain

  • Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Ixekizumab
    • Adalimumab
    Belgium Czechia France Germany Italy The Netherlands +1
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!